- Home
- NSPR vs CSBR Comparison
NSPR vs CSBR Comparison
Compare NSPR & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- CSBR
- Stock Information
- Founded
- NSPR 2005
- CSBR 1985
- Country
- NSPR Israel
- CSBR United States
- Employees
- NSPR N/A
- CSBR N/A
- Industry
- NSPR Medical/Dental Instruments
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NSPR Health Care
- CSBR Health Care
- Exchange
- NSPR Nasdaq
- CSBR Nasdaq
- Market Cap
- NSPR 63.0M
- CSBR 65.9M
- IPO Year
- NSPR N/A
- CSBR 1986
- Fundamental
- Price
- NSPR $2.45
- CSBR $4.55
- Analyst Decision
- NSPR Buy
- CSBR Strong Buy
- Analyst Count
- NSPR 1
- CSBR 1
- Target Price
- NSPR $4.50
- CSBR $6.00
- AVG Volume (30 Days)
- NSPR 36.4K
- CSBR 11.5K
- Earning Date
- NSPR 11-12-2024
- CSBR 12-10-2024
- Dividend Yield
- NSPR N/A
- CSBR N/A
- EPS Growth
- NSPR N/A
- CSBR N/A
- EPS
- NSPR N/A
- CSBR N/A
- Revenue
- NSPR $6,821,000.00
- CSBR $51,655,000.00
- Revenue This Year
- NSPR $12.28
- CSBR $9.27
- Revenue Next Year
- NSPR $53.44
- CSBR $9.76
- P/E Ratio
- NSPR N/A
- CSBR N/A
- Revenue Growth
- NSPR 24.70
- CSBR N/A
- 52 Week Low
- NSPR $1.81
- CSBR $3.60
- 52 Week High
- NSPR $3.42
- CSBR $7.13
- Technical
- Relative Strength Index (RSI)
- NSPR 61.14
- CSBR 57.46
- Support Level
- NSPR $2.07
- CSBR $4.30
- Resistance Level
- NSPR $3.05
- CSBR $4.58
- Average True Range (ATR)
- NSPR 0.22
- CSBR 0.23
- MACD
- NSPR 0.03
- CSBR 0.08
- Stochastic Oscillator
- NSPR 63.92
- CSBR 89.47
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.